Thomas Brabletz
Impact in
- Oncology top 0.1%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Oncology 84
- Cancer Cells and Metastasis 71
-
- MicroRNA in disease regulation 15
- Protease and Inhibitor Mechanisms 8
- Co-authors
- Simone Brabletz (30 shared papers)Thomas Kirchner (33 shared papers)Andreas Jung (35 shared papers)Falk Hlubek (21 shared papers)Otto Schmalhofer (10 shared papers)Simone Spaderna (14 shared papers)Marc P. Stemmler (31 shared papers)Maria Angela Nieto (3 shared papers)
- Journals
- Oncogene (8 papers)The Journal of Pathology (7 papers)Gastroenterology (7 papers)Oncotarget (7 papers)Nature Cell Biology (6 papers)
- Partner nations
- GermanyUnited StatesIsrael
In The Last Decade
Thomas Brabletz
184 papers receiving 26.7k citations
Thomas Brabletz's Hit Papers
Peers
Comparison fields: 5 of 123
- Oncology 10.8k
- Cancer Research 5.1k
- Molecular Biology 9.1k
- Immunology and Allergy 560
- Cell Biology 1.1k
Countries citing papers authored by Thomas Brabletz
This map shows the geographic impact of Thomas Brabletz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Brabletz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Brabletz more than expected).
Fields of papers citing papers by Thomas Brabletz
This network shows the impact of papers produced by Thomas Brabletz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Brabletz. The network helps show where Thomas Brabletz may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Brabletz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 187 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines and definitions for research on epithelial–mesenchymal transition Hit paper breakdown → | 2020 | 1621 |
| 2 | EMT in cancer Hit paper breakdown → | 2018 | 1597 |
| 3 | A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cells Hit paper breakdown → | 2008 | 1484 |
| 4 | The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs Hit paper breakdown → | 2009 | 1476 |
| 5 | Migrating cancer stem cells — an integrated concept of malignant tumour progression Hit paper breakdown → | 2005 | 1180 |
| 6 | Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment Hit paper breakdown → | 2001 | 913 |
| 7 | Oncogenic roles of EMT-inducing transcription factors Hit paper breakdown → | 2014 | 877 |
| 8 | The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer Hit paper breakdown → | 2017 | 809 |
| 9 | Wnt/β-catenin signaling in cancer stemness and malignant behavior Hit paper breakdown → | 2007 | 697 |
| 10 | The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer? Hit paper breakdown → | 2010 | 695 |
| 11 | E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer Hit paper breakdown → | 2009 | 672 |
| 12 | 1999 | 583 | |
| 13 | 2005 | 553 | |
| 14 | To differentiate or not — routes towards metastasis Hit paper breakdown → | 2012 | 535 |
| 15 | Dynamic EMT: a multi‐tool for tumor progression Hit paper breakdown → | 2021 | 531 |
| 16 | 2007 | 524 | |
| 17 | 2005 | 453 | |
| 18 | 2008 | 441 | |
| 19 | 2006 | 419 | |
| 20 | 2018 | 411 |
About Thomas Brabletz
Thomas Brabletz is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Immunology and Allergy, having authored 187 papers that have together received 27.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (71 papers), Wnt/β-catenin signaling in development and cancer (49 papers), MicroRNA in disease regulation (15 papers), Genetic factors in colorectal cancer (12 papers), Mechanisms of cancer metastasis (9 papers), Genomics and Chromatin Dynamics (9 papers), Protease and Inhibitor Mechanisms (8 papers) and Developmental Biology and Gene Regulation (8 papers). The work is most often cited by research in Oncology (10.8k citations), Cancer Research (5.1k citations), Molecular Biology (9.1k citations), Immunology and Allergy (560 citations) and Cell Biology (1.1k citations). Thomas Brabletz has collaborated with scholars based in Germany, United States and Israel. Frequent co-authors include Simone Brabletz, Thomas Kirchner, Andreas Jung, Falk Hlubek, Otto Schmalhofer, Simone Spaderna, Marc P. Stemmler, Maria Angela Nieto, Robert A. Weinberg and Raghu Kalluri. Their work appears in journals such as Oncogene, The Journal of Pathology, Gastroenterology, Oncotarget and Nature Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.